BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Second Quarter 2026 Results

Progyny (PGNY)ProgynyEarnings

Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDA Robust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building Solutions Value Returned to Shareholders Through the Repurchase of Over 2 Million Shares Under Current Authorization NEW YORK,

Related news

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

HSTMHealthStream2026-08-03 20:30 EST

HealthStream Announces Second Quarter 2026 Results

HSTMHealthStream2026-07-23 13:25 EST

HealthStream to Host Second Quarter 2026 Earnings Conference Call

TDOCTeladoc2026-07-29 20:05 EST

Teladoc Health Reports Second Quarter 2026 Results

SERASera Prognostics2026-07-29 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF SECOND QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON AUGUST 12, 2026

FEMYFEMASYS2026-05-08 20:05 EST

Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update

TXMDTherapeuticsMD2025-08-12 20:05 EST

TherapeuticsMD Announces Second Quarter 2025 Financial Results

TXMDTherapeuticsMD2024-08-12 20:05 EST

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TDOCTeladoc2026-07-15 20:05 EST

Teladoc Health to Announce Second Quarter 2026 Financial Results

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-08-07 14:51 EST

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

PGNYProgyny2026-08-06 20:01 EST

Progyny, Inc. Announces Second Quarter 2026 Results

PGNYProgyny2026-07-23 19:30 EST

Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

Stock data

Close
30.21 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States